0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > CD69

CD69

Brief Information

Name:DNA (cytosine-5)-methyltransferase 1
Target Synonym:Dnmt1,AIM,MCMT,DNA methyltransferase HsaI,DNA Methyltransferase 1,CXXC-Type Zinc Finger Protein 9,DNA MTase HsaI,M.HsaI,CXXC9,EC:2.1.1.37,DNA (Cytosine-5-)-Methyltransferase 1,DNMT,DNA (Cytosine-5)-Methyltransferase 1,EC 2.1.1.37,ADCADN,HSN1E
Number of Launched Drugs:5
Number of Drugs in Clinical Trials:8
Lastest Research Phase:Approved

Product ListCompare or Buy

Nach Produktstatus:
Nach Produktkategorie :
Nach Arten:
Nach Markierungen:
Nach Konjugaten:
Kat. Nr. Arten Produktbeschreibung Struktur Reinheit Merkmal
CD9-H5222 Human Human CD69 / CLEC2C Protein, His Tag
CD9-H5222-structure
CD9-H5222-sds
ACRO Quality

Synonym Name

CD69,CLEC2C,AIM,BL-AC/P26,EA1,GP32/28,MLR-3

Background

Early activation antigen CD69 is also known as C-type lectin domain family 2 member C (CLEC2C), Activation inducer molecule (AIM), Early T-cell activation antigen p60, Leukocyte surface antigen Leu-23. CD69 contains one C-type lectin domain. CD69 / CLEC2C is expressed on the surface of activated T-cells, B-cells, natural killer cells, neutrophils, eosinophils, epidermal Langerhans cells and platelets. CD69 is induced by antigens, mitogens or activators of PKC on the surface of T and B-lymphocytes and by interaction of IL-2 with the p75 IL-2R on the surface of NK cells. CD69 / CLEC2C involved in lymphocyte proliferation and functions as a signal transmitting receptor in lymphocytes, natural killer (NK) cells, and platelets.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Decitabine/Cedazuridine ASTX-727-LD; ASTX-727-10; E-7727/decitabine; Decitabine/E7727; ASTX-727 Approved Astex Pharmaceuticals Inc, National Cancer Institute INAQOVI, Inaqovi, Inqovi United States Myelodysplastic Syndromes Otsuka Pharmaceutical Co Ltd 2020-07-07 Leukemia, Myelogenous, Chronic; Leukemia; Solid tumours; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Neoplasms; Triple Negative Breast Neoplasms; Mesothelioma; Breast Neoplasms; Leukemia, Myeloid, Acute; Glioma; Nervous System Neoplasms; Neurilemmoma Details
Triclabendazole EGA-230B; CGA-89317; NVP-EGA230 Approved Novartis Pharma Ag Egaten, Fasinex, Triclathera Iran Fascioliasis Novartis Pharma Ag 1989-01-01 Fascioliasis Details
Mecobalamin E-0302 Approved Myelogen, Naso B12, NASOCOBAL, Methycobal, 弥尔神, 悦敏兴, RHINOCOBAL, 奇信, 曲力, 弥可保 Peripheral Nervous System Diseases; Autistic Disorder; Neuritis; Neuralgia; Vitamin B 12 Deficiency; Amyotrophic Lateral Sclerosis; Fibromyalgia Details
Decitabine 5-aza-CdR; NSC-127716; AzadC; E-7373; DAC Approved Eisai Co Ltd Dacogen, 达珂 Mainland China Myelodysplastic Syndromes Mgi Pharma Inc 2006-05-02 Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vulvar Neoplasms; Lymphoma, Mantle-Cell; Neuroblastoma; Breast Neoplasms; Lymphoma, Follicular; Colorectal Neoplasms; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Primary Myelofibrosis; Leukemia, Myeloid, Acute; Burkitt Lymphoma; Lung Neoplasms; Multiple Myeloma; Lymphoma; Thyroid Neoplasms; Anemia, Sickle Cell; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell; Myelodysplastic-Myeloproliferative Diseases; Neoplasm Metastasis; Thyroid Cancer, Papillary; Melanoma; Precancerous Conditions; Breast Neoplasms, Male; Leukemia, Myelomonocytic, Chronic; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Leukemia, Myelogenous, Chronic; Leukemia; Purpura, Thrombocytopenic, Idiopathic; Lymphoma, B-Cell, Marginal Zone; Solid tumours; Thalassemia; Neutropenia; Esophageal Neoplasms; Myelodysplastic Syndromes; Leukemia, Myeloid, Accelerated Phase; Myeloproliferative Disorders; Lymphoma, Large B-Cell, Diffuse; Small Cell Lung Details
Azacitidine 5-aza-CR; CC-486; NS-17; U-18496; NEX-18; NEX-18a; NSC-102816 Approved Celgene Corp 维达莎, Vidaza, Onureg United States Myelodysplastic Syndromes Bristol-Myers Squibb Company 2004-05-19 Leukemia, Myeloid, Acute; Immune System Diseases; Brain Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Tuberculosis, Pulmonary; Prostatic Neoplasms; Breast Neoplasms; Osteosarcoma; Sarcoma; Primary Myelofibrosis; Hepatic Insufficiency; Multiple Myeloma; Leukemia, Myelomonocytic, Juvenile; Lymphoma, Non-Hodgkin; Lymphoma; Thyroid Neoplasms; Lung Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Large Granular Lymphocytic; Carcinoma, Non-Small-Cell Lung; Melanoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelomonocytic, Chronic; Leukemia, Myelogenous, Chronic; Lymphoma, T-Cell, Peripheral; Hematologic Neoplasms; Solid tumours; Leukemia, Myeloid; Ependymoma; Head and Neck Neoplasms; Intestinal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Leukemia; Myelodysplastic Syndromes; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Nasopharyngeal Neoplasms; Glioblastoma; Small Cell Lung Carcino Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Curcumin VOLT-03; VOLT-3; NSC-32982 Phase 3 Clinical University Of Pennsylvania Lymphoma, T-Cell, Cutaneous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tobacco Use Disorder; Oral Submucous Fibrosis; Prostatic Neoplasms; Breast Neoplasms; Pancytopenia; Cognitive Dysfunction; Neuralgia; Colorectal Neoplasms; Dentist-Patient Relations; Cervical Intraepithelial Neoplasia; Uterine Cervical Dysplasia; Cigarette Smoking; Asthma; Primary Myelofibrosis; Urinary Incontinence, Urge; Adenocarcinoma, Mucinous; Lung Neoplasms; Lichen Planus, Oral; Renal Insufficiency, Chronic; Osteoarthritis; Carcinoma, Non-Small-Cell Lung; Crohn Disease; Adenocarcinoma; Aortic Aneurysm, Abdominal; Uterine Cervical Neoplasms; Stomatitis; Neoplasm Metastasis; Macular Degeneration; Thrombocythemia, Essential; Leukemia, Lymphocytic, Chronic, B-Cell; Arthritis, Rheumatoid; Primary Dysautonomias; Drug-Related Side Effects and Adverse Reactions; Hyperemia; Non-radiographic axial spondyloarthritis; Optic Atrophy, Hereditary, Leber; Depression; Gastritis, Atrophic; Rectal Neoplasms; Non-alcoholic Fatty Liver Disease; Dia Details
NTX-301 NTX-303 Phase 1 Clinical Southern Research Institute, Pinotbio Inc Solid tumours; Ovarian Neoplasms; Neoplasms; Carcinoma, Transitional Cell; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Glioma; Leukemia, Myeloid, Acute Details
Decitabine/Tetrahydrouridine EPI-01 Phase 2 Clinical Epicdestiny Anemia, Sickle Cell Details
Fluorocyclopentenylcytosine FCPEC; RX-3117; TV-1360; PCS-3117; RX 3117 Phase 2 Clinical Rexahn Pharmaceuticals Inc Solid tumours; Pancreatic Neoplasms; Urinary Bladder Neoplasms Details
Azacitidine/Cedazuridine ASTX-030 Phase 3 Clinical Otsuka Pharmaceutical Co Ltd Leukemia, Myelogenous, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute Details
FdCyd NSC-48006; Ro-5-1090 Phase 2 Clinical City Of Hope National Medical Center, National Cancer Institute Head and Neck Neoplasms; Esophageal Neoplasms; Neoplasms; Myelodysplastic Syndromes; Urinary Bladder Neoplasms; Mesothelioma; Breast Neoplasms; Lung Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Non-Small-Cell Lung Details
EF-009 EF-009 Phase 2 Clinical Everfront Biotech Co Ltd Pancreatic Neoplasms Details
Guadecitabine Sodium S-110; 0RB89YH367 (UNII code); SGI-110 Phase 3 Clinical Otsuka Holdings Co Ltd Klatskin Tumor; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma; Paraganglioma; Carcinoma, Hepatocellular; Gallbladder Neoplasms; Fallopian Tube Neoplasms; Lung Neoplasms; Leukemia, Myeloid, Acute; Peritoneal Neoplasms; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Cholangiocarcinoma; Chondrosarcoma; Prostatic Neoplasms, Castration-Resistant; Carcinoma, Transitional Cell; Pancreatic Neoplasms; Myeloproliferative Disorders; Small Cell Lung Carcinoma; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Carcinoma, Renal Cell; Pheochromocytoma; Stomach Neoplasms; Kidney Neoplasms; Ovarian Neoplasms Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Nachricht schicken